BioMark Diagnostics Inc. (BMKDF)
BMKDF Stock Price Chart
Explore BioMark Diagnostics Inc. interactive price chart. Choose custom timeframes to analyze BMKDF price movements and trends.
BMKDF Company Profile
Discover essential business fundamentals and corporate details for BioMark Diagnostics Inc. (BMKDF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
23 Mar 2015
Employees
—
CEO
Rashid Ahmed Maula Bux MBA
Description
BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
BMKDF Financial Timeline
Browse a chronological timeline of BioMark Diagnostics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
BMKDF Stock Performance
Access detailed BMKDF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.